BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3876235)

  • 21. The elastase inhibitory capacity and the alpha 1-proteinase inhibitor and bronchial inhibitor content of bronchoalveolar lavage fluids from healthy subjects.
    Boudier C; Pelletier A; Gast A; Tournier JM; Pauli G; Bieth JG
    Biol Chem Hoppe Seyler; 1987 Aug; 368(8):981-90. PubMed ID: 3311075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema.
    Fujita J; Nelson NL; Daughton DM; Dobry CA; Spurzem JR; Irino S; Rennard SI
    Am Rev Respir Dis; 1990 Jul; 142(1):57-62. PubMed ID: 2368980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and immunoreactive alpha 1 proteinase inhibitor in bronchoalveolar lavages: methodological studies.
    el Yamani J; Hayem A; Lafitte JJ; Gressier B; Mizon J
    Bull Eur Physiopathol Respir; 1986; 22(4):359-63. PubMed ID: 3094607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity.
    Carp H; Miller F; Hoidal JR; Janoff A
    Proc Natl Acad Sci U S A; 1982 Mar; 79(6):2041-5. PubMed ID: 6979049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratracheally-instilled antileukoprotease and alpha 1-proteinase inhibitor: effect on human neutrophil elastase-induced experimental emphysema and pulmonary localization.
    Rudolphus A; Kramps JA; Mauve I; Dijkman JH
    Histochem J; 1994 Oct; 26(10):817-24. PubMed ID: 7883591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor.
    Belorgey D; Bieth JG
    Biochemistry; 1998 Nov; 37(46):16416-22. PubMed ID: 9819234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of oxidative processes in emphysema.
    Janoff A; Carp H; Laurent P; Raju L
    Am Rev Respir Dis; 1983 Feb; 127(2):S31-8. PubMed ID: 6600889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse.
    Churg A; Wang RD; Xie C; Wright JL
    Am J Respir Crit Care Med; 2003 Jul; 168(2):199-207. PubMed ID: 12689849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidation of alpha 1-protease inhibitor: role of lipid peroxidation products.
    Mohsenin V; Gee JL
    J Appl Physiol (1985); 1989 May; 66(5):2211-5. PubMed ID: 2787317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases.
    Kouchi I; Yasuoka S; Ueda Y; Ogura T
    Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low molecular mass bronchial proteinase inhibitor and alpha 1-proteinase inhibitor in sputum and bronchoalveolar lavage.
    Stockley RA; Morrison HM; Smith S; Tetley T
    Hoppe Seylers Z Physiol Chem; 1984 May; 365(5):587-95. PubMed ID: 6332053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha 1-PI for emphysema due to alpha 1-antitrypsin deficiency.
    Horowitz ID; Schulman ES
    Am Fam Physician; 1989 Sep; 40(3):223-8. PubMed ID: 2672752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute effect of nitrogen dioxide exposure on the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage fluid of normal subjects.
    Mohsenin V; Gee JB
    Am Rev Respir Dis; 1987 Sep; 136(3):646-50. PubMed ID: 3498415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alpha 1-inhibitor of proteinases and its study in the clinic].
    Veremeenko KN
    Klin Med (Mosk); 1985 Dec; 63(12):21-7. PubMed ID: 3912607
    [No Abstract]   [Full Text] [Related]  

  • 35. The antielastase screen of the lower respiratory tract of alpha 1-proteinase inhibitor-sufficient patients with emphysema or pneumothorax.
    Gast A; Dietemann-Molard A; Pelletier A; Pauli G; Bieth JG
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):880-3. PubMed ID: 2327650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of catalase and methionine-S-oxide reductase on oxidised alpha 1-proteinase inhibitor.
    Morrison HM; Burnett D; Stockley RA
    Biol Chem Hoppe Seyler; 1986 May; 367(5):371-8. PubMed ID: 3527223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the turnover of methionine oxidized alpha-1-protease inhibitor in rats.
    Glaser CB; Karic L; Parmelee S; Premachandra BR; Hinkston D; Abrams WR
    Am Rev Respir Dis; 1987 Oct; 136(4):857-61. PubMed ID: 3499103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human neutrophil elastase does not bind to alpha 1-protease inhibitor that has been exposed to activated human neutrophils.
    Zaslow MC; Clark RA; Stone PJ; Calore JD; Snider GL; Franzblau C
    Am Rev Respir Dis; 1983 Sep; 128(3):434-9. PubMed ID: 6311062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of oxidized alpha-1-proteinase inhibitor in serum.
    Beatty K; Robertie P; Senior RM; Travis J
    J Lab Clin Med; 1982 Aug; 100(2):186-92. PubMed ID: 6178785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional alpha 1-protease inhibitor in the lower respiratory tract of cigarette smokers is not decreased.
    Stone PJ; Calore JD; McGowan SE; Bernardo J; Snider GL; Franzblau C
    Science; 1983 Sep; 221(4616):1187-9. PubMed ID: 6612333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.